Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial

Stimulating Factor ◽

Evaluation of the Quality of Life and Economic Burden with Granulocyte-Colony Stimulating Factor in Chinese Breast Cancer Patients Receiving Docetaxel, Epirubicin and Cyclophosphamide

Annals of Oncology ◽

10.1016/s0923-7534(20)34164-8 ◽

2012 ◽

Vol 23 ◽

pp. ix501

Author(s):

M. He ◽

S. Huang ◽

L. Yu ◽

G. Shi ◽

J. Deng ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Patients ◽

Economic Burden ◽

Breast Cancer Patients ◽

Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/87.17.1316 ◽

1995 ◽

Vol 87 (17) ◽

pp. 1316-1322 ◽

Cited By ~ 75

Author(s):

A. D. Seidman ◽

R. Portenoy ◽

T. -J. Yao ◽

J. Lepore ◽

E. K. Mont ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Predictive Value ◽

Phase Ii Trials ◽

Clinical predictors of failure of granulocyte colony stimulating factor (G-CSF) prophylaxis in patients with breast cancer treated with dose dense epirubicin (E), cyclophosphomide (C) + paclitaxel (T) Adjuvant chemotherapy: Subgroup analysis of the NCIC CTG MA.21 study (NCT00014222).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.1033 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 1033-1033

Author(s):

Ravi Ramjeesingh ◽

Janarthanan Kankesan ◽

Bingshu E. Chen ◽

Joseph L. Pater ◽

Lei Han ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Subgroup Analysis ◽

Clinical Predictors ◽

Dose Dense ◽

Stimulating Factor ◽

Granulocyte-Colony Stimulating Factor (G-CSF) Prophylaxis in Patients (ASA III & IV) with Colorectal Cancer: Feasibility and Impact on Quality of Life, Perioperative Cytokine Release and Complications

Anesthesiology ◽

10.1097/00000542-200209002-00369 ◽

2002 ◽

Vol 96 (Sup 2) ◽

pp. A369

Author(s):

Alexander Torossian ◽

Ulrike Plaul ◽

Hinnerk Wulf ◽

Wilfried Lorenz ◽

Artur Bauhofer.

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Cytokine Release ◽

Stimulating Factor ◽

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

Annals of Oncology ◽

10.1093/annonc/mdl135 ◽

2006 ◽

Vol 17 (8) ◽

pp. 1205-1212 ◽

Cited By ~ 139

Author(s):

M. Martín ◽

A. Lluch ◽

M.A. Seguí ◽

A. Ruiz ◽

M. Ramos ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Health Related Quality ◽

Breast Cancer Patients ◽

Related Quality ◽

Health Related ◽

449 Febrile Neutropenia (FN) in Early Breast Cancer Patients Receiving FEC-D – the Effect of Moving to Primary Granulocyte-colony Stimulating Factor (G-CSF) in the Mersey and Cheshire Cancer Network

European Journal of Cancer ◽

10.1016/s0959-8049(12)70514-2 ◽

2012 ◽

Vol 48 ◽

pp. S177-S178

Author(s):

A.P. Mullard ◽

S.M. O'Reilly ◽

Z. Ali ◽

P.S. Schofield ◽

Z.M. Malik ◽

...

Keyword(s):

Breast Cancer ◽

Febrile Neutropenia ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Cancer Network ◽

Stimulating Factor ◽

0199 The impact of adjuvant chemotherapy on quality of life in women with early breast cancer

The Breast ◽

10.1016/s0960-9776(09)70221-8 ◽

2009 ◽

Vol 18 ◽

pp. S69

Author(s):

G. Bulotiene ◽

V. Ostapenko

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Adjuvant Chemotherapy ◽

Early Breast Cancer ◽

The Impact

A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN

Annals of Oncology ◽

10.1093/annonc/mdv389 ◽

2015 ◽

Vol 26 (12) ◽

pp. 2437-2441 ◽

Cited By ~ 11

Author(s):

R.C.F. Leonard ◽

J.L. Mansi ◽

C. Keerie ◽

A. Yellowlees ◽

S. Crawford ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Randomised Trial ◽

Dose Intensity ◽

Secondary Prophylaxis ◽

Cooperative Group ◽

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

PharmacoEconomics ◽

10.2165/11589440-000000000-00000 ◽

2012 ◽

Vol 30 (2) ◽

pp. 103-118 ◽

Cited By ~ 7

Author(s):

Robert I. Griffiths ◽

Richard L. Barron ◽

Michelle L. Gleeson ◽

Mark D. Danese ◽

Anthony OʼHagan ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Older Patients ◽

Early Stage ◽

Medical Costs ◽

Early Stage Breast Cancer ◽

Abstract P1-09-01: Impact of Granulocyte-Colony Stimulating Factor (G-CSF) Use on Medical Costs after Initial Chemotherapy in Early-Stage Breast Cancer (ESBC)

10.1158/0008-5472.sabcs10-p1-09-01 ◽

2010 ◽

Author(s):

RI Griffiths ◽

RL Barron ◽

ML Gleeson ◽

MD Danese ◽

JC Legg ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Medical Costs ◽

Early Stage Breast Cancer ◽

Stimulating Factor ◽